표적 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 8.0%로, 1,514억 8,000만 달러로 성장합니다. 예측 기간의 성장은 종양학 연구 확대, 정밀의료에 대한 수요 증가, 면역 요법의 출현, 바이오의약품에 대한 투자 증가, 환자의 인식과 지지에 기인하는 것으로 추정됩니다. 예측 기간 중 주요 동향으로는 신약 개발에 인공지능(AI)의 통합, 치료 결정에 대한 환자 옹호 및 참여, 동반 진단 약물의 확대, 신속한 승인에 대한 규제 당국의 지원, 생명공학 및 제약에 대한 투자 증가 등이 있습니다.
암 발병률 증가는 향후 수년간 표적치료제 시장의 성장을 가속할 것으로 예상됩니다. 암은 주변 조직에 침입하여 통제할 수 없을 정도로 증식하는 비정상적인 세포를 특징으로 하는 질병군을 말합니다. 표적치료제는 암세포의 증식을 촉진하는 신호를 차단하거나 암세포의 자멸을 유도함으로써 효과를 발휘합니다. 암세포의 증식과 생존을 촉진하는 유전자나 단백질을 특이적으로 표적하도록 설계된 약물을 이용함으로써 그 수요가 증가하고 있습니다. 예를 들어 2024년 1월 미국에 본부를 둔 비영리단체인 미국암협회는 암 환자 수가 2023년 1,958,310명에서 2024년 2,001,140명으로 2.19% 증가할 것이라고 보고했습니다. 이처럼 암 유병률 증가는 표적치료제 시장의 성장을 가속할 것으로 예상됩니다.
이러한 성장은 정부의 구상과 자금 지원 증가로 인해 더욱 가속화될 것으로 예상됩니다. 정부의 구상과 자금 지원에는 의료, 과학, 기술, 교육 등 다양한 부문에 걸쳐 정부 기관이 제공하는 행동과 재정적 지원이 포함됩니다. 이러한 지원은 표적 치료의 추진에 중요한 역할을 하고 있으며, 정밀의료 연구개발에 중점을 두어 적응증 치료의 상업적 확장에 기여하고 있습니다.2023년 11월, 미국 국립 과학 및 공학 통계센터(National Center for Science and Engineering Statistics)는 2021년 연구개발비가 25억 1,300만 달러에서 5.2% 증가한 26억 4,400만 달러에 달할 것이라고 보고했습니다. 이러한 재정적 지원은 표적치료제 시장의 성장을 촉진하는 정부 지원의 역할을 강조하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, Covid, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 표적 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 용도 산업의 분석
- 세계의 표적 치료 시장 : 성장률 분석
- 세계의 표적 치료 시장 실적 : 규모와 성장, 2019-2024
- 세계의 표적 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 표적 치료 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 표적 치료 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 저분자 의약품
- 모노클로널 항체
- 세계의 표적 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 표적 치료 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 유방암
- 대장암
- 백혈병
- 폐암
- 림프종
- 신장암
- 기타 용도
- 세계의 표적 치료 시장, 저분자 의약품의 유형별 서브 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 티로신 키나아제 저해제(TKI)
- 프로테아좀 저해제
- Phosphatidylinositol 3-Kinase(PI3K) 저해제
- 기타 소분자 요법
- 세계의 표적 치료 시장, 모노클로널 항체의 유형별 서브 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 면역 체크포인트 저해제
- 항체약물접합체(ADC)
- 사이토카인 저해제
- 기타 모노클로널 항체
제7장 지역별·국가별 분석
- 세계의 표적 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 표적 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 표적 치료 시장 : 경쟁 구도
- 표적 치료 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Bayer AG
- Novartis AG
- Sanofi SA
- Bristol Myers Squibb
- AstraZeneca
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Gilead Sciences Inc.
- Amgen Inc.
- Genmab A/S
- Regeneron Pharmaceuticals Inc.
- Biogen Inc.
- Vertex Pharmaceuticals Incorporated
- Agilent Technologies Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 표적 치료 시장 2029 : 새로운 기회를 제공하는 국가
- 표적 치료 시장 2029 : 새로운 기회를 제공하는 부문
- 표적 치료 시장 2029 : 성장 전략
제36장 부록
KSA
Targeted therapy is a type of cancer treatment that utilizes medications or chemicals to specifically attack molecules crucial for the survival and spread of cancer cells. This approach involves drugs targeting specific genes and proteins that support the survival and growth of cancer cells.
Targeted therapy involves small molecule medicines and monoclonal antibodies. Small-molecule medicines are synthetic chemicals inspired by or derived from natural products, distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies. They are used for treating various cancers, including breast cancer, colorectal cancer, leukemia, lung cancer, lymphoma, and renal cancer.
The targeted therapy market research report is one of a series of new reports from The Business Research Company that provides targeted therapy market statistics, including targeted therapy industry global market size, regional shares, competitors with a targeted therapy market share, detailed targeted therapy market segments, market trends and opportunities, and any further data you may need to thrive in the targeted therapy industry. This targeted therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The targeted therapy market size has grown strongly in recent years. It will grow from $103.84 billion in 2024 to $111.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to advancements in molecular biology, increasing cancer incidence, personalized medicine trend, FDA approvals and regulatory support.
The targeted therapy market size is expected to see strong growth in the next few years. It will grow to $151.48 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to expanding oncology research, rising demand for precision medicine, emergence of immunotherapies, growing investment in biopharmaceuticals, patient awareness and advocacy. Major trends in the forecast period include integration of artificial intelligence (AI) in drug discovery, patient advocacy and involvement in treatment decisions, expansion of companion diagnostics, regulatory support for expedited approvals, increasing investment in biotechnology and pharma.
The rising incidence of cancer is anticipated to drive the growth of the targeted therapy market in the coming years. Cancer refers to a group of conditions characterized by abnormal cells that can invade surrounding tissues and proliferate uncontrollably. Targeted therapy works by interrupting the signals that promote the growth of cancer cells or by prompting these cells to self-destruct. It utilizes medications designed to specifically target the genes and proteins that facilitate the growth and survival of cancer cells, thereby increasing its demand. For example, in January 2024, the American Cancer Society, a nonprofit organization based in the U.S., reported that the number of cancer cases rose to 2,001,140, up from 1,958,310 in 2023, marking a growth of 2.19%. Thus, the increasing prevalence of cancer is expected to stimulate the growth of the targeted therapy market.
The anticipated growth is expected to be bolstered by increasing government initiatives and funding. Government initiatives and funding encompass actions and financial support provided by government agencies across various sectors, including healthcare, science, technology, and education. Such support plays a crucial role in advancing targeted therapies, with a focus on research and development in precision medicine contributing to the commercial expansion of adapted therapies. In November 2023, the National Center for Science and Engineering Statistics, a US-based agency, reported a 5.2% increase in expenditures on research and experimental development, reaching $2.644 billion compared to the 2021 expenditures of $2.513 billion. This financial backing underscores the role of government support in driving the growth of the targeted therapy market.
Major companies in the targeted therapy market are actively engaged in developing innovative technological solutions to enhance their market position. For instance, in March 2022, Novartis AG, a Swiss multinational pharmaceutical corporation, introduced Pluvicto, the first FDA-approved targeted radioligand therapy (RLT) for eligible patients with metastatic castration-resistant prostate cancer (mCRPC). Pluvicto combines a therapeutic radioisotope with a targeted chemical, representing a significant advancement in targeted cancer therapy. By binding to specific cells, including prostate cancer cells expressing the transmembrane protein PSMA, Pluvicto's radioisotope induces energy emissions that damage target cells and adjacent ones, impeding replication and potentially leading to cell death.
Companies in the targeted therapy market are also prioritizing strategic partnerships to enhance service offerings. One such example is Shine Technologies, a US-based pharmaceutical company specializing in radioactive isotopes, which partnered with Curadh MTR Inc. in September 2023. Curadh MTR Inc. focuses on advancing molecularly targeted radiation therapies for solid tumors. This collaboration aims to leverage radioisotopes' potential to precisely target and eliminate cancer cells, providing new prospects for patients and reshaping the landscape of cancer treatment.
In August 2022, Bristol Myers Squibb, a US-based biopharmaceutical company, made a strategic move by acquiring Turning Point Therapeutics for an undisclosed amount. This acquisition positions Bristol Myers Squibb to address a critical medical need for patients with non-small cell lung cancer testing positive for ROS1. Additionally, it grants access to a pipeline of experimental drugs, including repotrectinib, targeting prevalent mutations associated with oncogenesis. Turning Point Therapeutics, Inc., the acquired company, operates in the targeted therapy sector as a clinical-stage precision oncology company.
Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited
North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the targeted therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The targeted therapy market includes revenues earned by entities by providing various kinds of cancer drugs, such as EGFR inhibitors, angiogenesis inhibitors, and apoptosis inducers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Targeted Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on targeted therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for targeted therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The targeted therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Small Molecule Medicines; Monoclonal Antibodies
- 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- 3) By Application: Breast Cancer; Colorectal Cancer; Leukemia; Lung Cancer; Lymphoma; Renal Cancer; Other Applications
- Subsegments:
- 1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs); Proteasome Inhibitors; Phosphatidylinositol 3-Kinase (PI3K) Inhibitors; Other Small Molecule Therapies
- 2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors; Antibody-Drug Conjugates (ADCs); Cytokine Blockers; Other Monoclonal Antibodies
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd; Merck & Co Inc.; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Targeted Therapy Market Characteristics
3. Targeted Therapy Market Trends And Strategies
4. Targeted Therapy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Targeted Therapy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Targeted Therapy Market Growth Rate Analysis
- 5.4. Global Targeted Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Targeted Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Targeted Therapy Total Addressable Market (TAM)
6. Targeted Therapy Market Segmentation
- 6.1. Global Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Small Molecule Medicines
- Monoclonal Antibodies
- 6.2. Global Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.3. Global Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Lung Cancer
- Lymphoma
- Renal Cancer
- Other Applications
- 6.4. Global Targeted Therapy Market, Sub-Segmentation Of Small Molecule Medicines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tyrosine Kinase Inhibitors (TKIs)
- Proteasome Inhibitors
- Phosphatidylinositol 3-Kinase (PI3K) Inhibitors
- Other Small Molecule Therapies
- 6.5. Global Targeted Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immune Checkpoint Inhibitors
- Antibody-Drug Conjugates (ADCs)
- Cytokine Blockers
- Other Monoclonal Antibodies
7. Targeted Therapy Market Regional And Country Analysis
- 7.1. Global Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Targeted Therapy Market
- 8.1. Asia-Pacific Targeted Therapy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Targeted Therapy Market
- 9.1. China Targeted Therapy Market Overview
- 9.2. China Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Targeted Therapy Market
- 10.1. India Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Targeted Therapy Market
- 11.1. Japan Targeted Therapy Market Overview
- 11.2. Japan Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Targeted Therapy Market
- 12.1. Australia Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Targeted Therapy Market
- 13.1. Indonesia Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Targeted Therapy Market
- 14.1. South Korea Targeted Therapy Market Overview
- 14.2. South Korea Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Targeted Therapy Market
- 15.1. Western Europe Targeted Therapy Market Overview
- 15.2. Western Europe Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Targeted Therapy Market
- 16.1. UK Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Targeted Therapy Market
- 17.1. Germany Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Targeted Therapy Market
- 18.1. France Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Targeted Therapy Market
- 19.1. Italy Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Targeted Therapy Market
- 20.1. Spain Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Targeted Therapy Market
- 21.1. Eastern Europe Targeted Therapy Market Overview
- 21.2. Eastern Europe Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Targeted Therapy Market
- 22.1. Russia Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Targeted Therapy Market
- 23.1. North America Targeted Therapy Market Overview
- 23.2. North America Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Targeted Therapy Market
- 24.1. USA Targeted Therapy Market Overview
- 24.2. USA Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Targeted Therapy Market
- 25.1. Canada Targeted Therapy Market Overview
- 25.2. Canada Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Targeted Therapy Market
- 26.1. South America Targeted Therapy Market Overview
- 26.2. South America Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Targeted Therapy Market
- 27.1. Brazil Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Targeted Therapy Market
- 28.1. Middle East Targeted Therapy Market Overview
- 28.2. Middle East Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Targeted Therapy Market
- 29.1. Africa Targeted Therapy Market Overview
- 29.2. Africa Targeted Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Targeted Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Targeted Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Targeted Therapy Market Competitive Landscape And Company Profiles
- 30.1. Targeted Therapy Market Competitive Landscape
- 30.2. Targeted Therapy Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Targeted Therapy Market Other Major And Innovative Companies
- 31.1. Bayer AG
- 31.2. Novartis AG
- 31.3. Sanofi SA
- 31.4. Bristol Myers Squibb
- 31.5. AstraZeneca
- 31.6. GlaxoSmithKline plc
- 31.7. Takeda Pharmaceutical Company Limited
- 31.8. Eli Lilly and Company
- 31.9. Gilead Sciences Inc.
- 31.10. Amgen Inc.
- 31.11. Genmab A/S
- 31.12. Regeneron Pharmaceuticals Inc.
- 31.13. Biogen Inc.
- 31.14. Vertex Pharmaceuticals Incorporated
- 31.15. Agilent Technologies Inc.
32. Global Targeted Therapy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Targeted Therapy Market
34. Recent Developments In The Targeted Therapy Market
35. Targeted Therapy Market High Potential Countries, Segments and Strategies
- 35.1 Targeted Therapy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Targeted Therapy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Targeted Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
